mk 0663 has been researched along with h 89 in 1 studies
Studies (mk 0663) | Trials (mk 0663) | Recent Studies (post-2010) (mk 0663) | Studies (h 89) | Trials (h 89) | Recent Studies (post-2010) (h 89) |
---|---|---|---|---|---|
549 | 173 | 265 | 1,619 | 0 | 409 |
Protein | Taxonomy | mk 0663 (IC50) | h 89 (IC50) |
---|---|---|---|
Rho-associated protein kinase 2 | Homo sapiens (human) | 1.9504 | |
Ribosomal protein S6 kinase alpha-5 | Homo sapiens (human) | 0.12 | |
cAMP-dependent protein kinase catalytic subunit alpha | Bos taurus (cattle) | 0.073 | |
cAMP-dependent protein kinase catalytic subunit alpha | Mus musculus (house mouse) | 0.381 | |
cAMP-dependent protein kinase catalytic subunit alpha | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit gamma | Homo sapiens (human) | 0.6365 | |
cAMP-dependent protein kinase catalytic subunit beta | Homo sapiens (human) | 0.6365 | |
Ribosomal protein S6 kinase beta-1 | Homo sapiens (human) | 0.08 | |
RAC-alpha serine/threonine-protein kinase | Homo sapiens (human) | 1.9886 | |
RAC-beta serine/threonine-protein kinase | Homo sapiens (human) | 0.5417 | |
Rho-associated protein kinase 2 | Rattus norvegicus (Norway rat) | 0.27 | |
RAC-gamma serine/threonine-protein kinase | Homo sapiens (human) | 0.3207 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bretschneider, E; Censarek, P; Fischer, JW; Meyer-Kirchrath, J; Pape, R; Rabausch, K; Sarbia, M; Schrör, K; Weber, AA | 1 |
1 other study(ies) available for mk 0663 and h 89
Article | Year |
---|---|
Regulation of thrombomodulin expression in human vascular smooth muscle cells by COX-2-derived prostaglandins.
Topics: Alprostadil; Blood Coagulation; Bucladesine; Carotid Artery Diseases; Carotid Artery, Internal; Cells, Cultured; Colforsin; Coronary Vessels; Culture Media, Serum-Free; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Diclofenac; Dinoprostone; Epoprostenol; Etoricoxib; Gene Expression Profiling; Gene Expression Regulation; Humans; Iloprost; Isoquinolines; Mammary Arteries; Membrane Proteins; Models, Biological; Myocytes, Smooth Muscle; Oligonucleotide Array Sequence Analysis; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pyridines; Receptors, Prostaglandin; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP3 Subtype; RNA, Messenger; Saphenous Vein; Second Messenger Systems; Sulfonamides; Sulfones; Tetradecanoylphorbol Acetate; Thrombomodulin; Thrombophilia; Vasodilator Agents | 2005 |